IVDR Technical Documentation2025-09-12T03:26:25+05:30
IVDR Technical Documentation

our approach aimed at maximizing productivity & efficiency.

IVDR Technical Documentation

Under the new EU In Vitro Diagnostic Regulation (IVDR 2017/746), every IVD device placed on the EU market must have complete Technical Documentation (TD). This is required because:

  1. Demonstrates Compliance: It proves that the device meets General Safety and Performance Requirements (GSPR) outlined in IVDR Annex I.

  2. Notified Body Review and Approval: Without TD, the manufacturer cannot obtain or maintain CE Certification.

  3. Ensures Transparency & Traceability: Authorities, Notified Bodies, and Competent Authorities can review it during conformity assessments, audits, or inspections.

  4. Patient Safety & Performance: IVDR Technical Documentation includes risk management, performance evaluation, and analytical data to confirm that the device is safe and performs as intended.

  5. Regulatory Obligation: Article 10(4) of IVDR makes technical documentation mandatory for all manufacturers (whether self-certified or via a Notified Body).

Role of Consultants in IVDR Technical Documentation

Preparing IVDR Technical Documentation is complex, especially with stricter requirements compared to IVDD. Consultants help by:

  • Gap Assessment

    Reviewing existing files (IVDD-era files) and identifying missing elements needed for IVDR compliance.

  • Structuring the Documentation

    Organizing files per IVDR Annex II & III requirements (Device description, design & manufacturing, GSPR checklist, performance evaluation, PMS/PMCF plans, risk management, etc.).

  • Performance Evaluation

    Supporting in literature search, clinical data appraisal, and preparation of Performance Evaluation Report (PER).

  • Liaising with Notified Bodies

    Preparing documentation in the exact format expected, handling questions, and responding to review comments.

  • Reducing Regulatory Risk

    Ensuring that the documentation is audit-ready, avoiding costly delays or rejections

  • Training & Process Setup

    Helping manufacturers build internal capability for Post-Market Surveillance (PMS) and Periodic Safety Update Reports (PSUR) under IVDR.

Overall IVDR CE Marking Process

  1. Classify device (A, B, C, D).

  2. Implement ISO 13485 QMS.

  3. Prepare Technical Documentation & Performance Evaluation.

  4. Undergo Notified Body review + onsite audit.

  5. Obtain CE Certificate → Affix CE Mark → Maintain compliance via PMS.

service related FAQ’s

Transfer of US Agent Possible? Explain the process2025-07-31T14:12:58+05:30

Yes, manufacturers / exporter any time they can transfer the US Agent. We are happy to act as US Agent for any non-US manufacturers.  Please bring us the FDA FURLS account login details to update the Agent Information.

Who needs to comply with EU MDR 2017/745?2025-08-03T08:55:10+05:30

All medical device manufacturers intending to sell devices in the EU, including Class I, IIa, IIb, and III must comply with the MDR.

Is appointing an EC REP mandatory for CE marking?2025-08-05T10:27:37+05:30

Yes. If your company is based outside the EEA and wishes to market medical devices or IVDs in Europe, it is legally required to appoint an EC REP. This representative’s name and address must appear on the product labeling, outer packaging, or Instructions for Use (IFU).

What Documents and how to submit 510k file?2025-07-30T09:38:17+05:30

The 510(k) file includes documents used to establish the safety and efficiency of the proposed medical device through substantial equivalence. The documents included in the 510(k) file are:

  1. Form FDA 3601: Medical Device User Fee Cover Sheet (MDUFC sheet)
  2. FDA Form 3514- CDRH Premarket Review Submission Cover Sheet: This document includes basic administrative and device information.
  3. 510(k) Cover Letter: This document provides a brief idea about the purpose of the submission, device, manufacturer and the U.S agent (if any).
  4. FDA Form 3881: Indications for Use Statement
  5. 510(k) Summary or 510(k) Statement: This includes a summary of the device undergoing the 510(k) clearance.
  6. Truthful & Accuracy Statement: This is to certify that the 510(k) submission contents are truthful and accurate and no information omitted.
  7. Class III Summary and Certification: If the proposed device is a Class III exempt from PMA, otherwise, this can be marked as not applicable.
  8. Financial Certification or Disclosure Statement: This is applicable only if clinical studies were conducted
  9. Declarations of Conformity and Summary Reports: Lists the voluntary consensus standards used and includes DOC to such standards.
  10. Device Description: This document includes the description of the device design requirements and performance specifications.
  11. Executive Summary: a brief description of the device & comparison table with the predicate device identified.
  12. Substantial Equivalence Discussion: Detailed comparison between the proposed device and the predicate device chosen.
  13. Proposed Labeling: Is discussed in detail to comply with 21 CFR 807.87(e) for general medical devices and 21 CFR 809.10 for IVD’s
  14. Sterilization and Shelf Life: This document provides details regarding the sterilization and shelf life claim being made.
  15. Biocompatibility: This document is applicable if the proposed device comes into direct or indirect contact with the human body tissue.
  16. Software: This includes the documentation for any software used in the proposed device
  17. Electromagnetic Compatibility and Electrical Safety- If the proposed device is powered electrically, in which case the EMC must be evaluated.
  18. Performance Testing – Bench: This document included details of the bench tests performed to evaluate the efficiency of the proposed device.
  19. Performance Testing – Animal: This document included details of the animal testing performed to evaluate the efficiency of the proposed device.
  20. Performance Testing – Clinical: This document included details of the clinical studies performed to evaluate the efficiency of the proposed device.

The completed FDA 510(k) file is submitted in electronic format as an e-copy to the FDA. The submission package is sent to the CDRH through registered mail or commercial delivery service.

What is the usual timeline for IVD Class B,C and D device CE Certification2025-08-01T11:56:40+05:30

Based on the number of models and varients the timeline may change. usually the timeline for class B is approx 8-10 montsh and Class D is 14 months.

get a free quote
Go to Top